Nagano, Japan

Takeshi Masaki




Average Co-Inventor Count = 5.4

ph-index = 1


Location History:

  • Nagano, JP (2019 - 2020)
  • Matsumoto, JP (2021)

Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Inventor Takeshi Masaki

Introduction

Takeshi Masaki is a notable inventor based in Nagano, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for ischemic diseases. With a total of 4 patents, his work focuses on innovative methods for gene delivery and treatment.

Latest Patents

Masaki's latest patents include a therapeutic agent for ischemic diseases. This invention provides a transformation plasmid for transforming anaerobes, enabling highly efficient and stable secretory expression of a target protein. Additionally, it includes a gene delivery carrier formed from the transformed anaerobes, a pharmaceutical composition incorporating this carrier, and methods for diagnosing or treating ischemic diseases. Another significant patent is a co-expression plasmid aimed at providing an anaerobic enterobacterium with enhanced therapeutic effects on anaerobic sites, such as solid tumor tissues and ischemic disease sites. This bacterium is transformed with a plasmid that co-expresses two types of heterologous polypeptides, efficiently secreting antibodies with anticancer effects.

Career Highlights

Throughout his career, Takeshi Masaki has worked with prominent organizations, including Anaeropharma Science, Inc. and Shinshu University. His research has been pivotal in advancing therapeutic strategies for complex medical conditions.

Collaborations

Masaki has collaborated with notable colleagues, including Yuko Shimatani and Hitomi Shimizu. Their combined expertise has contributed to the success of his innovative projects.

Conclusion

Takeshi Masaki's contributions to biotechnology and his innovative patents reflect his dedication to improving therapeutic options for ischemic diseases. His work continues to inspire advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…